Wealthcare Advisory Partners LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 97 filers reported holding CYTOSORBENTS CORP in Q3 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealthcare Advisory Partners LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2021$505,000
+7.4%
62,1870.0%0.03%
+6.5%
Q2 2021$470,000
-13.0%
62,1870.0%0.03%
-20.5%
Q1 2021$540,000
+8.9%
62,1870.0%0.04%
-11.4%
Q4 2020$496,0000.0%62,1870.0%0.04%
-18.5%
Q3 2020$496,000
-19.5%
62,1870.0%0.05%
-29.9%
Q2 2020$616,000
+28.1%
62,1870.0%0.08%
+8.5%
Q1 2020$481,000
+100.4%
62,187
-0.1%
0.07%
+129.0%
Q4 2019$240,000
-23.3%
62,2790.0%0.03%
-31.1%
Q3 2019$313,000
-23.7%
62,279
+0.3%
0.04%
-30.8%
Q2 2019$410,000
-12.8%
62,0790.0%0.06%
-18.8%
Q1 2019$470,000
-6.4%
62,0790.0%0.08%
-17.5%
Q4 2018$502,000
-37.3%
62,0790.0%0.10%
-34.0%
Q3 2018$801,000
+13.1%
62,0790.0%0.15%
+5.8%
Q2 2018$708,000
+61.6%
62,0790.0%0.14%
+40.4%
Q1 2018$438,000
+14.4%
62,079
+5.4%
0.10%
+1.0%
Q4 2017$383,000
+4.9%
58,8990.0%0.10%
-9.3%
Q3 2017$365,00058,8990.11%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
CM Management, LLC 675,000$918,0001.02%
Sargent Investment Group, LLC 1,108,233$2,028,0000.63%
Skylands Capital, LLC 2,347,034$3,192,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,000$344,0000.37%
Avenir Corp 2,314,854$3,148,0000.33%
Granahan Investment Management 1,511,029$2,055,0000.07%
ACT CAPITAL MANAGEMENT, LLC 35,000$48,0000.07%
Winning Points Advisors, LLC 22,900$33,0000.04%
Cowen Prime Advisors LLC 42,200$57,0000.03%
Seelaus Asset Management LLC 23,900$33,0000.03%
View complete list of CYTOSORBENTS CORP shareholders